Chubb and Marsh develop $150mn Covax compensation scheme
Chubb and Marsh have structured a $150mn no-fault compensation scheme for citizens of 92 lower-income countries who suffer a serious adverse reaction to a Covid-19 vaccine.
If you are a subscriber, please sign back in to read this article
If you are not currently a subscriber please see contact details below